Reed Elsevier PLC
27 February 2008
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
27 February 2008
Director/PDMR Shareholding
Reed Elsevier received notification today that the following shares were
acquired on 26 February 2008 by the individuals noted below, following
reinvestment of the special distribution paid to ordinary shareholders last
month.
DIRECTORS OF REED ELSEVIER PLC AND REED ELSEVIER NV
Mark Armour acquired 3,640 Reed Elsevier PLC shares at 627.00p per share and
2,379 Reed Elsevier NV shares at €12.31 per share.
Erik Engstrom acquired 219 Reed Elsevier PLC ADRs at $49.70 per ADR and 1,781
Reed Elsevier NV ADRs at $36.77 per ADR.
Andrew Prozes acquired 1,235 Reed Elsevier PLC ADRs at $49.91 per ADR and 1,820
Reed Elsevier NV ADRs at $36.98 per ADR.
As a result of these transactions the interests in the ordinary share capital of
Reed Elsevier for the above directors is now as follows:
Director Current interest in Current interest in
Reed Elsevier PLC Reed Elsevier NV
ordinary shares ordinary shares
Mark Armour 100,922 43,464
Erik Engstrom 69,592 193,894
Andrew Prozes 204,893 150,227
PDMR
Nick Baker acquired 2,376 Reed Elsevier PLC shares at 627.00p per share.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.